• Does not cure MS, but it can reduce the number of MS relapses• Can also help to slow down or reverse some of the signs and symptoms of MS• Patients treated with LEMTRADA had fewer relapses and were less likely to experience worsening of their disability compared to patients treated with a beta-interferon. Here, IFNB1 is linked to myeloid sarcoma.